2024
Barriers to and facilitators of improving physical activity and nutrition behaviors during chemotherapy for breast cancer: a sequential mixed methods study
Puklin L, Irwin M, Sanft T, Ferrucci L, Harrigan M, McGowan C, Cartmel B, Zupa M, Winer E, Deyling M, Ligibel J, Basen-Engquist K, Spiegelman D, Sharifi M. Barriers to and facilitators of improving physical activity and nutrition behaviors during chemotherapy for breast cancer: a sequential mixed methods study. Supportive Care In Cancer 2024, 32: 590. PMID: 39141176, DOI: 10.1007/s00520-024-08789-5.Peer-Reviewed Original ResearchConceptsPhysical activityLifestyle interventionSelf-reported PA questionnaireSelf-reported diet qualityBreast cancerHealthy Eating Index-2015Stage I-III breast cancerBenefits of PASequential mixed methods studyI-III breast cancerChemotherapy-related symptomsMixed methods studyThematic content analysisBehavioral goalsSense of controlBody mass indexPA questionnaireSemi-structured interviewsMean body mass indexTranscribed verbatimIntervention armTailored educationDiet qualityNutritional behaviorMental benefits
2022
Exercise adherence in a randomized controlled trial of exercise on quality of life in ovarian cancer survivors
Cao A, Cartmel B, Li F, Gottlieb L, Harrigan M, Ligibel J, Gogoi R, Schwartz P, Irwin M, Ferrucci L. Exercise adherence in a randomized controlled trial of exercise on quality of life in ovarian cancer survivors. Journal Of Cancer Survivorship 2022, 17: 535-543. PMID: 36550261, PMCID: PMC10038915, DOI: 10.1007/s11764-022-01325-6.Peer-Reviewed Original ResearchConceptsOvarian cancer survivorsMin/weekCancer survivorsExercise goalsCancer recurrenceCounseling sessionsSession attendanceExercise adherenceHigher baseline activity levelsWeekly exercise durationTrial of exerciseMean exercise timeVigorous-intensity exerciseBaseline activity levelsQuality of lifeMore counseling sessionsExercise interventionExercise durationWeek exerciseLifestyle StudyExercise timeOvarian cancerNumber of sessionsCounseling intensitySurvivors
2018
Concordance of cancer registry and self-reported race, ethnicity, and cancer type: a report from the American Cancer Society’s studies of cancer survivors
Layne TM, Ferrucci LM, Jones BA, Smith T, Gonsalves L, Cartmel B. Concordance of cancer registry and self-reported race, ethnicity, and cancer type: a report from the American Cancer Society’s studies of cancer survivors. Cancer Causes & Control 2018, 30: 21-29. PMID: 30392148, DOI: 10.1007/s10552-018-1091-3.Peer-Reviewed Original Research
2016
Health information needs and preferences in relation to survivorship care plans of long-term cancer survivors in the American Cancer Society’s Study of Cancer Survivors-I
Playdon M, Ferrucci LM, McCorkle R, Stein KD, Cannady R, Sanft T, Cartmel B. Health information needs and preferences in relation to survivorship care plans of long-term cancer survivors in the American Cancer Society’s Study of Cancer Survivors-I. Journal Of Cancer Survivorship 2016, 10: 674-685. PMID: 26744339, PMCID: PMC5032143, DOI: 10.1007/s11764-015-0513-4.Peer-Reviewed Original ResearchConceptsLong-term cancer survivorsCancer survivorsCare plansAmerican Cancer Society's StudySurvivorship care plansTime of diagnosisLong-term survivorsSelf-reported poor healthLate cancer stageHealth informationHealth care providersNon-Hispanic whitesCONCLUSIONS/IMPLICATIONSGreater informational needsMethodsCancer survivorsUsual careCancer characteristicsCancer patientsCommon cancerCancer stageTreatment summaryBreast cancerCare providersSurvey 9Younger age
2013
Single v. multiple measures of skin carotenoids by resonance Raman spectroscopy as a biomarker of usual carotenoid status
Scarmo S, Cartmel B, Lin H, Leffell DJ, Ermakov IV, Gellermann W, Bernstein PS, Mayne ST. Single v. multiple measures of skin carotenoids by resonance Raman spectroscopy as a biomarker of usual carotenoid status. British Journal Of Nutrition 2013, 110: 911-917. PMID: 23351238, PMCID: PMC3696054, DOI: 10.1017/s000711451200582x.Peer-Reviewed Original ResearchConceptsSkin carotenoid statusRecent sun exposureCarotenoid statusSkin carotenoidsSun exposureRR measuresFruit/vegetable intakeLower carotenoid statusSeason of measurementMean ageNon-invasive methodVegetable intakeInverse associationDietary dataTime pointsSignificant predictorsMultiple measuresPositive associationIntakeBiomarkersPresent studyStatusPredictorsAssociationExposure
2012
Employment experience of cancer survivors 2 years post-diagnosis in the Study of Cancer Survivors-I
Yu M, Ferrucci LM, McCorkle R, Ercolano E, Smith T, Stein KD, Cartmel B. Employment experience of cancer survivors 2 years post-diagnosis in the Study of Cancer Survivors-I. Journal Of Cancer Survivorship 2012, 6: 210-218. PMID: 22215311, DOI: 10.1007/s11764-011-0212-8.Peer-Reviewed Original ResearchConceptsCancer survivorsCancer survivors 2 yearsCancer survivor populationMultivariate logistic regressionSurvivors 2 yearsCancer survivors 2Lower household incomeSurvivorship yearsSurvivors 2Work status changesPsychosocial measuresOlder agePsychosocial characteristicsSurvivor populationLogistic regressionPotential predictorsSurvivorsWork-related experiencesLongitudinal studyStatus changesSurvivors' experiencesAdditional researchPredictorsYearsHealth
2010
Noninvasive assessment of dermal carotenoids as a biomarker of fruit and vegetable intake
Mayne ST, Cartmel B, Scarmo S, Lin H, Leffell DJ, Welch E, Ermakov I, Bhosale P, Bernstein PS, Gellermann W. Noninvasive assessment of dermal carotenoids as a biomarker of fruit and vegetable intake. American Journal Of Clinical Nutrition 2010, 92: 794-800. PMID: 20685953, PMCID: PMC3133234, DOI: 10.3945/ajcn.2010.29707.Peer-Reviewed Original ResearchConceptsIntraclass correlation coefficientDermal carotenoidsDermal biopsiesRR measuresBiomarkers of fruitDietary carotenoid intakeVegetable intakeCarotenoid statusCarotenoid intakeStudy of nutritionNoninvasive assessmentBiopsyBiomarkersSkin pigmentationTotal carotenoidsHuman skinIntakeWkInner armLycopeneValid methodArm
2001
Predictors for cutaneous basal‐ and squamous‐cell carcinoma among actinically damaged adults
Foote J, Harris R, Giuliano A, Roe D, Moon T, Cartmel B, Alberts D. Predictors for cutaneous basal‐ and squamous‐cell carcinoma among actinically damaged adults. International Journal Of Cancer 2001, 95: 7-11. PMID: 11241303, PMCID: PMC2637530, DOI: 10.1002/1097-0215(20010120)95:1<7::aid-ijc1001>3.0.co;2-x.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaSkin cancerRisk factorsNon-melanoma skin cancerSCC incidence ratesAge 61 yearsRed hair colorGroup of menActinic lesionsBCC occurrencePlacebo groupChemoprevention trialsCutaneous basalBCC lesionsMale genderIncidence ratePrior historySun damageSubstantial incidenceOlder ageCancerFirst SCCExposure factorsAdult residenceCarcinoma
1999
Predictors of participant retention in two chemoprevention feasibility trials
Bowen D, Cartmel B, Barnett M, Goodman G, Omenn G. Predictors of participant retention in two chemoprevention feasibility trials. Annals Of Behavioral Medicine 1999, 21: 210-215. PMID: 10626026, DOI: 10.1007/bf02884835.Peer-Reviewed Original ResearchConceptsPilot study participantsPilot studyClinical trialsEfficacy trialsStudy participantsLong-term clinical trialsAsbestos-exposed participantsRetinol Efficacy TrialAsbestos-exposed workersHigh blood pressureCancer chemoprevention trialsGeneral health issuesFull-scale efficacy trialHigher baseline levelsMental health measuresRetention of participantsOnly significant predictorCurrent smokersBlood pressureChemoprevention trialsFeasibility trialPredictors of retentionPrevention StudyBaseline predictorsBaseline levelsEffects of long-term intake of retinol on selected clinical and laboratory indexes
Cartmel B, Moon T, Levine N. Effects of long-term intake of retinol on selected clinical and laboratory indexes. American Journal Of Clinical Nutrition 1999, 69: 937-943. PMID: 10232634, DOI: 10.1093/ajcn/69.5.937.Peer-Reviewed Original ResearchConceptsRetinol intakeAdverse effectsLaboratory indicesVitamin A/dCoronary artery disease riskCancer chemoprevention trialsLong-term ingestionMinimal adverse effectsLong-term intakeSkin cancer chemoprevention trialAlkaline phosphataseMedian followPlacebo groupChemoprevention trialsClinical symptomsRetinol groupChemopreventive agentsCholesterol concentrationsHealthy populationSkin cancerModerate riskDisease riskIntakeFurther studiesSignificant differencesPlasma Lycopene Concentrations in Humans Are Determined by Lycopene Intake, Plasma Cholesterol Concentrations and Selected Demographic Factors 1 , 2
Mayne S, Cartmel B, Silva F, Kim C, Fallon B, Briskin K, Zheng T, Baum M, Shor-Posner G, Goodwin W. Plasma Lycopene Concentrations in Humans Are Determined by Lycopene Intake, Plasma Cholesterol Concentrations and Selected Demographic Factors 1 , 2. Journal Of Nutrition 1999, 129: 849-854. PMID: 10203560, DOI: 10.1093/jn/129.4.849.Peer-Reviewed Original ResearchConceptsPlasma lycopene levelsPlasma lycopene concentrationsPlasma cholesterolLycopene levelsPlasma lycopeneLycopene intakeLycopene concentrationHigher plasma lycopene concentrationsNonwhite race/ethnicityDietary lycopene intakeCancer Prevention TrialMarital statusLow dietary intakeLower plasma cholesterolPlasma cholesterol concentrationLow plasma concentrationsLess vitamin CRace/ethnicityPrevention trialsDietary lycopeneTriglyceride levelsUnivariate analysisDietary intakeChronic diseasesPlasma concentrations
1997
Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Moon T, Levine N, Cartmel B, Bangert J, Rodney S, Dong Q, Peng Y, Alberts D. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiology Biomarkers & Prevention 1997, 6: 949-56. PMID: 9367069.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaNew squamous-cell carcinomasModerate-risk subjectsSkin cancerHazard ratioNew nonmelanoma skin cancersSquamous cell skin cancerIU of retinolNew skin cancersPlacebo-supplemented subjectsPrimary end pointNonmelanoma skin cancerFree-living subjectsEffect of retinolMedian followOral retinolBasal cell carcinoma skin cancersActinic keratosesRetinol supplementationCell carcinomaDaily supplementationAdverse symptomsEnd pointCancerNew BCCTrial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Levine N, Moon T, Cartmel B, Bangert J, Rodney S, Dong Q, Peng Y, Alberts D. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiology Biomarkers & Prevention 1997, 6: 957-61. PMID: 9367070.Peer-Reviewed Original ResearchConceptsCutaneous squamous cell carcinomaSquamous cell carcinomaBasal cell carcinomaNonmelanoma skin cancerCell carcinomaSkin cancerPlacebo-controlled trialHigh-risk subjectsSkin cancer preventionEffect of retinolOral retinolStudy clinicCancer preventionOutcome measuresIsotretinoinBeneficial effectsStudy periodRetinolTrialsCarcinomaCancerPreventionTotal numberParticipantsPlaceboRetinoids in prevention of skin cancer
Moon T, Levine N, Cartmel B, Bangert J. Retinoids in prevention of skin cancer. Cancer Letters 1997, 114: 203-205. PMID: 9103292, DOI: 10.1016/s0304-3835(97)04663-6.Peer-Reviewed Original ResearchConceptsBasal cell skin cancerModerate-risk subjectsPrior skin cancersHigh-risk subjectsRisk subjectsSkin cancerB trialSquamous cell skin cancerSquamous cell cancerEffects of retinoidsActinic keratosesCell cancerClinical trialsIntervention durationCancerTrialsRetinolRetinoidsPlaceboIncidencePreventionSubjectsSignificant benefitsIsotretinoinKeratoses
1995
Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group.
Moon T, Levine N, Cartmel B, Bangert J, Rodney S, Schreiber M, Peng Y, Ritenbaugh C, Meyskens F, Alberts D. Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group. Cancer Epidemiology Biomarkers & Prevention 1995, 4: 661-9. PMID: 8547834.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaBasal cell carcinomaSkin cancer prevention trialCancer Prevention TrialHigh-risk individualsB participantsPrevention trialsCell carcinomaDaily supplementationPlacebo-controlled clinical trialCutaneous squamous cell carcinomaSkin cancer incidenceDermatologist referralCancer RegistryAdditional clinicsCancer incidenceClinical trialsStudy groupSkin cancerB trialClinicTrialsEnrollment goalsCarcinomaIncidence